Evropska unija - estonščina - EMA (European Medicines Agency)

pfizer europe ma eeig - lorlatinib - kartsinoom, mitteväikerakk-kopsu - antineoplastic agents, protein kinase inhibitors - lorviqua as monotherapy is indicated for the treatment of adult patients with anaplastic lymphoma kinase (alk)‑positive advanced non‑small cell lung cancer (nsclc) previously not treated with an alk inhibitor. lorviqua as monotherapy is indicated for the treatment of adult patients with alk‑positive advanced nsclc whose disease has progressed after:alectinib or ceritinib as the first alk tyrosine kinase inhibitor (tki) therapy; orcrizotinib and at least one other alk tki.

Estonija - estonščina - Ravimiamet

krka, d.d., novo mesto - valsartaan - õhukese polümeerikattega tablett - 40mg 56tk; 40mg 7tk; 40mg 10tk; 40mg 180tk; 40mg 30tk; 40mg 14tk; 40mg 28tk; 40mg 50tk; 40mg 60tk

Estonija - estonščina - Ravimiamet

alvogen ipco s.a.r.l. - kapetsitabiin - õhukese polümeerikattega tablett - 500mg 120tk

Estonija - estonščina - Ravimiamet

norbrook laboratories (ireland) limited - deltametriin - täpilahus - 10mg 1ml 250ml 1tk; 10mg 1ml 1000ml 1tk; 10mg 1ml 500ml 2tk; 10mg 1ml 500ml 1tk

Estonija - estonščina - Ravimiamet

orion corporation - formoterool+budesoniid - inhalatsioonipulber - 4,5mcg+80mcg 1annus 60annus 1tk; 4,5mcg+80mcg 1annus 60annus 3tk; 4,5mcg+80mcg 1annus 120annus 1tk; 4,5mcg+80mcg 1annus 120annus 3tk

Estonija - estonščina - Ravimiamet

norbrook laboratories (ireland) limited - fiproniil - täpilahus - 268mg 2.68ml 2.68ml 120tk; 268mg 2.68ml 2.68ml 60tk; 268mg 2.68ml 2.68ml 150tk; 268mg 2.68ml 2.68ml 90tk; 268mg 2.68ml 2.68ml 8tk; 268mg 2.68ml 2.68ml 24tk; 268mg 2.68ml 2.68ml 4tk; 268mg 2.68ml 2.68ml 6tk; 268mg 2.68ml 2.68ml 30tk; 268mg 2.68ml 2.68ml 12tk; 268mg 2.68ml 2.68ml 1tk; 268mg 2.68ml 2.68ml 2tk

Estonija - estonščina - Ravimiamet

sandoz pharmaceuticals d.d. - salmeterool+flutikasoon - annustatud inhalatsioonipulber - 50mcg+500mcg 60annus 1tk; 50mcg+500mcg 60annus 2tk; 50mcg+500mcg 60annus 3tk; 50mcg+500mcg 60annus 4tk; 50mcg+500mcg 60annus 6tk

Estonija - estonščina - Ravimiamet

medochemie limited - valsartaan - õhukese polümeerikattega tablett - 160mg 280tk; 160mg 56tk; 160mg 90tk; 160mg 60tk; 160mg 30tk; 160mg 7tk

Estonija - estonščina - Ravimiamet

fresenius kabi polska sp. z o.o. - gemtsitabiin - infusioonilahuse kontsentraat - 38mg 1ml 52.6ml 1tk; 38mg 1ml 5.26ml 1tk; 38mg 1ml 26.3ml 1tk

Estonija - estonščina - Ravimiamet

sandoz pharmaceuticals d.d. - salmeterool+flutikasoon - annustatud inhalatsioonipulber - 50mcg+250mcg 60annus 6tk; 50mcg+250mcg 60annus 2tk; 50mcg+250mcg 60annus 3tk; 50mcg+250mcg 60annus 1tk